Clinical Trials Browser

Lymphoma, Extranodal NK-T-Cell × selinexor × 90 days × Clear all

NCT07554482 2026-04-28

Selinexor Combined With Reduced-Dose Radiotherapy For Early-Stage Extranodal NK/T-Cell Lymphoma

Phase 2 Not yet recruiting

Lymphoma, Extranodal NK-T-Cell